Physician profile
Nianjun Tang
NPI 1477556454
$544.07
in general payments reported to CMS, 2019-2025
10 companies · $34.19 in 2025
The $34.19 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.88 · 2020: $34.87 · 2021: $33.92 · 2022: $92.61 · 2023: $324 · 2025: $34.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $319.81 | 2022-2023 | |
| Spr Therapeutics, INC | $56.00 | 2022 | |
| Forte Bio-Pharma LLC | $38.28 | 2020-2021 | |
| Biotronik Nro, INC. | $34.19 | 2025 | Prospera |
| Nalu Medical, INC. | $22.37 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.03 | 2023 | Relistor |
| Si-Bone, INC. | $15.50 | 2021 | |
| Medtronic USA, INC. | $15.01 | 2020 | |
| Kaleo, INC. | $13.00 | 2019 | |
| Amgen INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nianjun Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.